medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2003, Number 1

<< Back Next >>

Rev Inst Nal Enf Resp Mex 2003; 16 (1)

Molecular bases of the Mycobacterium tuberculosis-macrophage interaction.

Trejo MH, Gorocica P, Porras F, Chávez R, Lascurain R, Zenteno E

Language: Spanish
References: 61
Page: 41-47
PDF size: 63.91 Kb.


ABSTRACT

Molecular interaction between Mycobacterium tuberculosis and macrophages determines the fate of bacilli within the host cell. In this molecular interaction, some components of the bacterial surface are recognized as ligands by macrophage receptors. The present article is an updated review of the molecular characteristics of the mycobacteria-host interaction.


REFERENCES

  1. Collins HL, Kaufmann SH. The many faces of host responses to tuberculosis. Immunology 2001;103:1-9.

  2. Sudre P, Ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull WHO 1992;70:149-159.

  3. Bloom BR, Murray JL. Tuberculosis: commentary on a reemergent killer. Science 1992;257:1055-1064.

  4. Fenton MJ, Vermeulen MW. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect Immun 1996;64:683-690.

  5. Flynn J, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001;19:93-129.

  6. Linehan SH, Martínez-Pomares L, Gordon S. Macrophage lectins in host defense. Microb Infect 2000;2:279-288.

  7. Barnes PF, Mehra V, Hirschfield R, Fong J, Abou-Zeid GA, Rook W, et al. Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis. J Immunol 1989;143:2656-2662.

  8. Monahan I, Betts J, Dilip K, Banerjee, Butcher P. Differential expression of mycobacterial proteins following phagocytosis by macrophages. Microbiol 2001;147:459-471.

  9. Brennan PJ. Structure of mycobacteria: Recent developments in defining cell wall carbohydrates and proteins. Rev Infect Dis 1989;11:S420-S430.

  10. Schlesinger LS, Kaufman T, Lyer S, Hull S, Marchiando LK. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J Immunol 1996;157:4568-4575.

  11. Hirsch CS, Ellner J, Russell DG, Rich AE. Complement receptor-mediated uptake and tumor necrosis factor alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol 1994;52:743-753.

  12. Schlesinger LS. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 1993;150:2920-2930.

  13. Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 1990;144:2771-2780.

  14. Aderem A, Underhill M. Mechanisms of phagocytosis in macrophages. Ann Rev Immunol 1999;17:593-623.

  15. Sastry K, Ezekowitz RA. Collectins: pattern recognition molecules involved in first line host defense. Curr Opin Immunol 1993;5:59-66.

  16. Voorhout WF, Veenendaal T, Kuroki Y, Ogasawara Y, Van Golde LM, Geuze HJ. Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, clara cells, and alveolar macrophages of rat lung. J Histochem Cytochem 1992;40:1589-1592.

  17. Epstein J, Eichbaum Q, Sheriff S, Ezekowitz RA. The collectins in innate immunity. Curr Opin Immunol 1996;8:29-35.

  18. Ernst JD. Macrophage receptors for Mycobacterium tuberculosis. Minireview. Infect Immun 1998;66:1277-1281.

  19. Nepomuceno RR, Henschen-Edman HA, Burgess H, Tenner A. cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 1997;6:119-129.

  20. Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller YA. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 1997;7:345-355.

  21. Chroneos ZC, Abdolrasulnia R, Whitsett JA, Rice WR, Shepherd VL. Purification of a cell-surface receptor for surfactant protein. A J Biol Chem 1996;271:16375-16383.

  22. Carroll MC. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 1998;16:545-568.

  23. Brown EJ. Complement receptors and phagocytosis. Curr Opin Immunol 1991;3:76-82.

  24. Albert RK, Embree LJ, McFeely JE, Hickstein DD. Expression and function of beta 2 integrins on alveolar macrophages from human and nonhuman primates. Am J Respir Cell Mol Biol 1992;7:182-189.

  25. Cywes C, Godeneir HC, Hoppe RR, Scholle LM, Steyn RE, Kirsch MR, et al. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect Immunol 1996;64: 5373-5383.

  26. Cywes C, Hoppe HC, Dafne M, Ehlers MR. Nonopsonic binding of Mycobactecterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent. Infect Immun 1997;65:4258-4266.

  27. Schorey JS, Carroll MC, Brown EJ. A macrophage invasion mechanism of pathogenic mycobacteria. Science 1997;277:1091-1093.

  28. Armstrong JA, Hart PD. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli reversal of the usual nonconfusion pattern and observations on bacterial survival. J Exp Med 1975;142:1-16.

  29. Ravetch JV, Clynes RA. Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 1998;16:421-432.

  30. Ravetch JV. Fc receptors. Curr Opin Immunol 1997;9:121-125.

  31. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001;19:275-290.

  32. Allen LAH, Aderem A. Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor mediated phagocytosis in macrophages. J Exp Med 1996;184:627-637.

  33. Ezeckowitz RA, Sastry K, Baillo P, Warner A. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeast in Cos-I cells. J Exp Med 1990;172:1785-1794.

  34. Ziegler-Heitbrock HWL, Ulevitch RJ. CD14: Cell surface receptor and differentiation marker. Immunol Today 1993;14:121-125.

  35. Besra GS, Chatterjee D. Lipids and carbohydrates of Mycobacterium tuberculosis. In: Bloom BR, editor. Tuberculosis: pathogenesis, protection, and control. Washington DC: ASM Press, 1994:285-306.

  36. Bernardo J, Billingslea AM, Blumenthal RL, Seetoon KF, Simons ER, Fenton MJ. Differential response of human mononuclear phagocytes to mycobacterial lipoarabinomannans: role of CD14 and mannose receptor. Infect Immun 1998;66:28-35.

  37. Thomas CJ, Kapoor M, Sharma S, Bausinger H, Zyilan U, Lipsker D, et al. Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS response. FEBS Lett 2002;531:184-188.

  38. Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu M, Nishijima MP, et al. CD14 is a pattern recognition receptor. Immunity 1994;1:509-516.

  39. Stenger S, Aderem A. Role of Toll-like receptors in inflammatory response in macrophage. Crit Care Med 2001;29 suppl:116-158.

  40. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, et al. Toll-like receptor-2 mediates lipopolysacharide-induced cellular signaling. Nature 1998;395:284-288.

  41. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998;392:505-509.

  42. Schlesinger LS. Entry of Mycobacterium tuberculosis into mononuclear phagocytes. Curr Topics Microbiol Immunol 1996;215:71-96.

  43. Schlesinger LS, Hull SR, Kaufman TM. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol 1994;152:4070-4079.

  44. Sthal PD, Ezekowitz RA. The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 1998;10:50-55.

  45. Astarie-Dequeker C, N’Diaye EN, Le Cabec V, Ritting MG, Prandi J, Maridonneau-Parini I. The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages. Infect Immun 1999;67:469-477.

  46. Beharka AA, Gaynor CD, Kang BK, Voelker DR, McCormack FX, Schlesinger LS. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol 2002;1:3565-3573.

  47. Bermudez L, Champsi J. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibodies associated with enhanced resistance to infection in mice. Immun 1993;61: 3093-3097.

  48. Nigou J, Zelle-Rieser C, Gilleron M, Thurnher M, Puzo G. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J Immunol 2001;166: 7477-7485.

  49. Berman JS, Blumenthal RL, Kornfeld H, Cook JA, Cruikshank WW, Vermeulen MW, et al. Chemeotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitro. J Immunol 1996;15:3828-3835.

  50. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of lipid antigen by CD1-restricted ab+T cells. Nature 1994;372:691-694.

  51. Prigozy TI, Sieling PA, Clemens D, Stewart PL, Behar SM, Porcelli SA, et al. The mannose receptor delivers lipoglycan antigens to endocites for presentation to T cells by CD1b molecules. Immunity 1997;6:187-197.

  52. Boom WH, Chervenak KA, Mincek MA, Ellner JJ. Role of the mononuclear phagocyte as an antigen-presenting cell for human gd-T cells activated by live Mycobacterium tuberculosis. Infect Immun 1992;60:3480-3488.

  53. Dunne DW, Resnick D, Grenberg J, Krieger M, Joiner KA. The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc Natl Acad Sci 1994;91:1863-1867.

  54. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 1994;63:601-637.

  55. Zimmerli S, Edwards S, Ernst JD. Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am J Respir Cell Mol Biol 1996;15:760-770.

  56. Savill J. Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull 1997;53:491-508.

  57. Tenner AJ, Robinson SL, Ezekowitz RA. Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M(r) component of the C1q receptor. Immunity 1995;3:485-493.

  58. O’Riordan M, Yi CH, Gonzales R, Lee KD, Portnoy DA. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc Natl Acad Sci 2002;99:13861-13866.

  59. Gatfield J, Pieters J. Essential role for cholesterol in entry of mycobacteria into macrophages. Science 2000; 288:1647-1650.

  60. Ferrari G, Langen H, Naito M, Pieters J. A coat protein on phagosomes envolved in the intracellular survival of mycobacteria. Cell 1999;97:435-447.

  61. Russell DG. Mycobacterium and Leishmania: Stowaways in the endosamal network. Trends Cell Biol 1995;5:125-128.




2020     |     www.medigraphic.com